SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) today announced the appointment of Catherine J. Friedman to its board of directors. Ms. Friedman is currently a consultant to companies in the life sciences industry. Prior to last year, she was an investment banker at Morgan Stanley for over 23 years.
